Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Portion-controlled spinach for improved vitamin K antagonist anticoagulant control.

Card DJ, Hall A, Watson HG, Kitchen DP, Harrington DJ.

Br J Haematol. 2020 Feb 3. doi: 10.1111/bjh.16481. [Epub ahead of print] No abstract available.

PMID:
32017038
2.

Characterization and treatment of congenital thrombotic thrombocytopenic purpura.

Alwan F, Vendramin C, Liesner R, Clark A, Lester W, Dutt T, Thomas W, Gooding R, Biss T, Watson HG, Cooper N, Rayment R, Cranfield T, van Veen JJ, Hill QA, Davis S, Motwani J, Bhatnagar N, Priddee N, David M, Crowley MP, Alamelu J, Lyall H, Westwood JP, Thomas M, Scully M.

Blood. 2019 Apr 11;133(15):1644-1651. doi: 10.1182/blood-2018-11-884700. Epub 2019 Feb 15. Review.

PMID:
30770395
3.

Haemoglobin Titusville: low oxygen saturations but is the patient hypoxaemic?

Zaidi MH, Fryer D, Barr C, Watson HG.

QJM. 2018 Dec 1;111(12):893-894. doi: 10.1093/qjmed/hcy202. No abstract available.

PMID:
30202934
4.

Reducing the use of inappropriate coagulation testing in emergency general surgical patients.

Thomas L, Woon E, Fong E, Parnaby C, Watson HG.

Scott Med J. 2018 May;63(2):45-50. doi: 10.1177/0036933018760762. Epub 2018 Jun 26.

PMID:
29945493
5.

Measurement of rivaroxaban concentrations demonstrates lack of clinical utility of a PT, dPT and APTT test in estimating levels.

Thom I, Cameron G, Robertson D, Watson HG.

Int J Lab Hematol. 2018 Aug;40(4):493-499. doi: 10.1111/ijlh.12846. Epub 2018 May 2.

PMID:
29718586
6.

Autologous 111 In-labelled platelet scan as a predictor of splenectomy outcome in ITP.

Kazi S, Mckiddie F, Anderson J, Bagot C, Duncan C, Drummond M, Kerr R, Khan M, McColl M, Roddie H, Priddee N, Staff R, Thomas R, Watson HG.

Br J Haematol. 2019 Mar;184(6):1043-1045. doi: 10.1111/bjh.15236. Epub 2018 Apr 20. No abstract available.

PMID:
29676450
7.

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.

Alwan F, Vendramin C, Vanhoorelbeke K, Langley K, McDonald V, Austin S, Clark A, Lester W, Gooding R, Biss T, Dutt T, Cooper N, Chapman O, Cranfield T, Douglas K, Watson HG, van Veen JJ, Sibson K, Thomas W, Manson L, Hill QA, Benjamin S, Ellis D, Westwood JP, Thomas M, Scully M.

Blood. 2017 Jul 27;130(4):466-471. doi: 10.1182/blood-2016-12-758656. Epub 2017 Jun 2.

PMID:
28576877
8.

Defective α2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.

Mitchell JL, Wright S, Kazi S, Watson HG, Mutch NJ.

Br J Haematol. 2017 Sep;178(5):794-799. doi: 10.1111/bjh.14759. Epub 2017 May 17.

PMID:
28516512
9.

A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.

Thachil J, Bagot C, Bradbury C, Cooper N, Lester W, Grainger JD, Lowe G, Evans G, Talks K, Sibson K, Garg M, Murphy MF, Watson HG, Bolton-Maggs PHB, Watson S, Scully M, Provan D, Newland A, Hill QA.

Br J Haematol. 2018 Feb;180(4):591-594. doi: 10.1111/bjh.14395. Epub 2016 Nov 23. No abstract available.

PMID:
27879997
10.

Spontaneous bilateral breast haemorrhagic necrosis.

De Gabriele S, Macmillan MT, Nomikos A, Tahhan M, Masannat Y, Depasquale I, Miller I, Watson HG.

Br J Haematol. 2017 Feb;176(4):666-668. doi: 10.1111/bjh.13980. Epub 2016 Feb 23. No abstract available.

PMID:
26914631
11.

An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm.

Olaiya A, Lurie B, Watt B, McDonald L, Greaves M, Watson HG.

J Thromb Haemost. 2016 May;14(5):987-90. doi: 10.1111/jth.13288. Epub 2016 Mar 21.

12.

The impact of cell labelling technique on the retention of indium-labelled platelet imaging for idiopathic thrombocytopenic purpura.

McKiddie FI, Watson HG, Graham D, Phillips J, Staff RT.

Nucl Med Commun. 2016 Feb;37(2):215-6. doi: 10.1097/MNM.0000000000000447. No abstract available.

PMID:
26695446
13.

Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.

Schmitz-Abe K, Ciesielski SJ, Schmidt PJ, Campagna DR, Rahimov F, Schilke BA, Cuijpers M, Rieneck K, Lausen B, Linenberger ML, Sendamarai AK, Guo C, Hofmann I, Newburger PE, Matthews D, Shimamura A, Snijders PJ, Towne MC, Niemeyer CM, Watson HG, Dziegiel MH, Heeney MM, May A, Bottomley SS, Swinkels DW, Markianos K, Craig EA, Fleming MD.

Blood. 2015 Dec 17;126(25):2734-8. doi: 10.1182/blood-2015-09-659854. Epub 2015 Oct 21.

14.

Guideline on aspects of cancer-related venous thrombosis.

Watson HG, Keeling DM, Laffan M, Tait RC, Makris M; British Committee for Standards in Haematology.

Br J Haematol. 2015 Sep;170(5):640-8. doi: 10.1111/bjh.13556. Epub 2015 Jun 26. Review.

PMID:
26114207
15.

Oral direct inhibitors of coagulation.

Watson HG.

J R Coll Physicians Edinb. 2014;44(1):46-9. doi: 10.4997/JRCPE.2014.111. Review.

PMID:
24995448
16.

Hepatitis C infection and outcomes in the Scottish haemophilia population.

Khan MM, Tait RC, Kerr R, Ludlam CA, Lowe GD, Murray W, Watson HG.

Haemophilia. 2013 Nov;19(6):870-5. doi: 10.1111/hae.12218. Epub 2013 Jun 20.

PMID:
23786361
17.

Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand disease.

Watson HG, Wilde JT, Dolan G, Millar C, Yee TT, Makris M; Morbidity and Mortality Working Party UKHCDO.

Haemophilia. 2013 May;19(3):e191-2. doi: 10.1111/hae.12139. No abstract available.

PMID:
23600911
18.

Destination healthcare facility of shocked trauma patients in Scotland: analysis of transfusion and surgical capability of receiving hospitals.

Peach CM, Morrison JJ, Apodaca AN, Egan G, Watson HG, Jansen JO.

Surgeon. 2013 Oct;11(5):272-7. doi: 10.1016/j.surge.2013.01.003. Epub 2013 Feb 9.

PMID:
23402864
19.

Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding.

Watson HG.

Evid Based Nurs. 2013 Jul;16(3):92-3. doi: 10.1136/eb-2012-100896. Epub 2012 Nov 23. No abstract available.

PMID:
23178311
20.

Perceived hazards of transfusion: can a clinician tool help patients' understanding?

Khan MH, Watson HG, Dombrowski SU.

Transfus Med. 2012 Aug;22(4):294-7. doi: 10.1111/j.1365-3148.2012.01165.x. Epub 2012 Jun 25.

PMID:
22724532
21.

Preservation of small bowel with the selective use of heparin and second look laparotomy in acute mesenteric ischaemia: A case report.

Fouad D, Nanthakumaran S, Watson HG, Millar CG, King PM.

Int J Surg Case Rep. 2012;3(7):260-2. doi: 10.1016/j.ijscr.2012.03.007. Epub 2012 Mar 20.

22.

Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage.

Chee YL, Townend J, Crowther M, Smith N, Watson HG.

Haemophilia. 2012 Jul;18(4):593-7. doi: 10.1111/j.1365-2516.2012.02750.x. Epub 2012 Feb 15.

PMID:
22335463
23.

The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation].

Thachil J, Toh CH, Levi M, Watson HG.

Br J Haematol. 2012 May;157(4):493-4. doi: 10.1111/j.1365-2141.2011.09019.x. Epub 2012 Jan 9. No abstract available.

PMID:
22225506
24.

UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011.

Wilde JT, Mutimer D, Dolan G, Millar C, Watson HG, Yee TT, Makris M.

Haemophilia. 2011 Sep;17(5):e877-83. doi: 10.1111/j.1365-2516.2011.02585.x. Epub 2011 Jun 9. Review.

PMID:
21658165
25.

RVO--real value obscure.

Watson HG.

J Thromb Haemost. 2011 Jun;9(6):1116-8. doi: 10.1111/j.1538-7836.2011.04296.x.

26.

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom.

Guest JF, Watson HG, Limaye S.

Clin Ther. 2010 Dec;32(14):2478-93. doi: 10.1016/j.clinthera.2011.01.011.

PMID:
21353116
27.

Heparin-induced thrombocytopenia and the utility of the 4Ts score in the Intensive Care Unit.

Khan MM, Noble DW, Watson HG.

Br J Haematol. 2011 Mar;152(5):672-4. doi: 10.1111/j.1365-2141.2010.08436.x. Epub 2011 Jan 23. No abstract available.

PMID:
21255001
28.

Guidelines on travel-related venous thrombosis.

Watson HG, Baglin TP.

Br J Haematol. 2011 Jan;152(1):31-4. doi: 10.1111/j.1365-2141.2010.08408.x. Epub 2010 Nov 18. Review.

PMID:
21083651
29.

Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.

Jin Y, Hu D, Peterson EL, Eng C, Levin AM, Wells K, Beckman K, Kumar R, Seibold MA, Karungi G, Zoratti A, Gaggin J, Campbell J, Galanter J, Chapela R, Rodríguez-Santana JR, Watson HG, Meade K, Lenoir M, Rodríguez-Cintrón W, Avila PC, Lanfear DE, Burchard EG, Williams LK.

J Allergy Clin Immunol. 2010 Sep;126(3):618-25.e1-2. doi: 10.1016/j.jaci.2010.06.007. Epub 2010 Jul 31.

30.

Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis.

Mutch NJ, Koikkalainen JS, Fraser SR, Duthie KM, Griffin M, Mitchell J, Watson HG, Booth NA.

J Thromb Haemost. 2010 Sep;8(9):2017-24. doi: 10.1111/j.1538-7836.2010.03963.x.

31.

Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma.

Corvol H, De Giacomo A, Eng C, Seibold M, Ziv E, Chapela R, Rodriguez-Santana JR, Rodriguez-Cintron W, Thyne S, Watson HG, Meade K, LeNoir M, Avila PC, Choudhry S, Burchard EG; Genetics of Asthma in Latino Americans (GALA) Study; Study of African-Americans, Asthma, Genes and Environments (SAGE) Investigators.

Pharmacogenet Genomics. 2009 Jul;19(7):489-96. doi: 10.1097/FPC.0b013e32832c440e.

32.

Differential enzymatic activity of common haplotypic versions of the human acidic Mammalian chitinase protein.

Seibold MA, Reese TA, Choudhry S, Salam MT, Beckman K, Eng C, Atakilit A, Meade K, Lenoir M, Watson HG, Thyne S, Kumar R, Weiss KB, Grammer LC, Avila P, Schleimer RP, Fahy JV, Rodriguez-Santana J, Rodriguez-Cintron W, Boot RG, Sheppard D, Gilliland FD, Locksley RM, Burchard EG.

J Biol Chem. 2009 Jul 17;284(29):19650-8. doi: 10.1074/jbc.M109.012443. Epub 2009 May 12.

33.

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.

Levi M, Toh CH, Thachil J, Watson HG.

Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12.

PMID:
19222477
34.

Survival after sequential mechanical complications of acute myocardial infarction, complicated with heparin-induced thrombocytopenia and multiple organ failure: report of a case.

Kallikourdis A, Jacob S, Watson HG, Gibson G.

J Card Surg. 2008 Jul-Aug;23(4):381-4. doi: 10.1111/j.1540-8191.2008.00615.x.

PMID:
18598334
35.

Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients.

Naqvi M, Tcheurekdjian H, DeBoard JA, Williams LK, Navarro D, Castro RA, Rodriguez-Santana JR, Chapela R, Watson HG, Meade K, Rodriguez-Cintron W, LeNoir M, Thyne SM, Avila PC, Choudhry S, Burchard EG.

Ann Allergy Asthma Immunol. 2008 Jun;100(6):551-7. doi: 10.1016/S1081-1206(10)60055-5.

PMID:
18592818
36.

Upper extremity deep vein thrombosis--not the same disease at a different site.

WATSON HG.

J Thromb Haemost. 2008 Aug;6(8):1267-8. doi: 10.1111/j.1538-7836.2008.03061.x. No abstract available.

37.

An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity.

Seibold MA, Wang B, Eng C, Kumar G, Beckman KB, Sen S, Choudhry S, Meade K, Lenoir M, Watson HG, Thyne S, Williams LK, Kumar R, Weiss KB, Grammer LC, Avila PC, Schleimer RP, Burchard EG, Brenner R.

Hum Mol Genet. 2008 Sep 1;17(17):2681-90. doi: 10.1093/hmg/ddn168. Epub 2008 Jun 4.

38.

Can we predict bleeding?

Watson HG, Greaves M.

Semin Thromb Hemost. 2008 Feb;34(1):97-103. doi: 10.1055/s-2008-1066028. Review.

PMID:
18393146
39.

ORMDL3 gene is associated with asthma in three ethnically diverse populations.

Galanter J, Choudhry S, Eng C, Nazario S, Rodríguez-Santana JR, Casal J, Torres-Palacios A, Salas J, Chapela R, Watson HG, Meade K, LeNoir M, Rodríguez-Cintrón W, Avila PC, Burchard EG.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1194-200. doi: 10.1164/rccm.200711-1644OC. Epub 2008 Feb 28.

40.

Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology.

Chee YL, Crawford JC, Watson HG, Greaves M.

Br J Haematol. 2008 Mar;140(5):496-504. doi: 10.1111/j.1365-2141.2007.06968.x. Review.

PMID:
18275427
41.

Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism.

Watson HG, Chee YL.

Blood Rev. 2008 Mar;22(2):107-16. doi: 10.1016/j.blre.2007.11.001. Epub 2008 Jan 15. Review.

PMID:
18226435
42.

Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma.

Naqvi M, Thyne S, Choudhry S, Tsai HJ, Navarro D, Castro RA, Nazario S, Rodriguez-Santana JR, Casal J, Torres A, Chapela R, Watson HG, Meade K, LeNoir M, Avila PC, Rodriguez-Cintron W, Burchard EG.

J Asthma. 2007 Oct;44(8):639-48.

PMID:
17943575
43.

Approach to the diagnosis and management of mild bleeding disorders.

Greaves M, Watson HG.

J Thromb Haemost. 2007 Jul;5 Suppl 1:167-74. Review.

44.

Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies.

Robertson B, Urquhart C, Ford I, Townend J, Watson HG, Vickers MA, Greaves M.

J Thromb Haemost. 2007 Aug;5(8):1679-85. Epub 2007 May 21.

45.

Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma.

Naqvi M, Choudhry S, Tsai HJ, Thyne S, Navarro D, Nazario S, Rodriguez-Santana JR, Casal J, Torres A, Chapela R, Watson HG, Meade K, Rodriguez-Cintron W, Lenoir M, Avila PC, Burchard EG.

J Allergy Clin Immunol. 2007 Jul;120(1):137-43. Epub 2007 May 11.

PMID:
17498790
46.

Sex hormones and thrombosis.

Watson HG.

Semin Hematol. 2007 Apr;44(2):98-105. Review.

PMID:
17433902
47.

Ethnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma.

Battle NC, Choudhry S, Tsai HJ, Eng C, Kumar G, Beckman KB, Naqvi M, Meade K, Watson HG, Lenoir M, Burchard EG; SAGE Investigators.

Am J Respir Crit Care Med. 2007 May 1;175(9):881-7. Epub 2007 Feb 15.

48.

Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura.

Sukati H, Watson HG, Urbaniak SJ, Barker RN.

Blood. 2007 May 15;109(10):4528-38. Epub 2007 Feb 1.

PMID:
17272505
49.

The PTGDR gene is not associated with asthma in 3 ethnically diverse populations.

Tsai YJ, Choudhry S, Kho J, Beckman K, Tsai HJ, Navarro D, Matallana H, Castro RA, Lilly CM, Nazario S, Rodriguez-Santana JR, Casal J, Torres A, Salas J, Chapela R, Watson HG, Meade K, Avila PC, Rodriguez-Cintron W, LeNoir M, Burchard EG; Genetics of Asthma in Latino Americans Study; Study of African Americans, Asthma, Genes and Environments Investigators.

J Allergy Clin Immunol. 2006 Dec;118(6):1242-8. Epub 2006 Sep 26.

PMID:
17157653
50.

Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency.

Baglin TP, Cousins D, Keeling DM, Perry DJ, Watson HG.

Br J Haematol. 2007 Jan;136(1):26-9. Epub 2006 Nov 20. No abstract available. Erratum in: Br J Haematol. 2007 Feb;136(4):681.

PMID:
17116128

Supplemental Content

Loading ...
Support Center